Skip to main content
    C

    Compass Therapeutics Inc. (CMPX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.66
    -0.11 (-14.51%)

    Market Cap: $139.35M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    41%(9/22)
    Avg Surprise
    -5.21%

    Upcoming Estimates

    Reports Mar 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.15
    Range-$0.17 - -$0.13
    17 analysts
    Revenue Consensus
    N/A
    RangeN/A
    16 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.13
    Range-$0.16 - -$0.11
    6 analysts
    EPS Revisions
    3
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.14+7.1%
    60d ago-$0.15+11.2%
    30d ago-$0.130.0%
    7d ago-$0.130.0%
    Current-$0.13
    Revenue Consensus
    N/A
    RangeN/A
    9 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-49.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio6.79xQuick Ratio6.79x
    Trading Statistics
    Beta1.06Avg Volume2.07M
    52-Week High$6.8852-Week Low$0.67

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 39.9% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 29.9, below 30, the oversold line.

    Moving Averages

    SMA 10$0.77
    SMA 20$0.77
    SMA 50$1.10
    SMA 200$2.90
    EMA 10$0.77
    EMA 20$0.82
    EMA 50$1.11
    EMA 200$2.34

    MACD

    Line: -0.09Signal: -0.11Hist: 0.02

    ADX

    ADX: 45.8+DI: 15.2-DI: 36.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$0.90

    Bollinger Bands

    Upper Band$0.87
    Lower Band$0.68
    %B Position2455%(Upper)
    Band Width-0.10

    RSI (14-Day)

    Oversold
    29.9

    Momentum Oscillators

    Stoch %K37.5
    Stoch %D56.3
    Williams %R-99.4
    ROC (10d)-13.8%
    Momentum-0.11
    CCI (20d)-166.3
    MFI (14d)61.0

    Volatility Measures

    ATR (14d)$0.07(11.0%)
    StdDev (20d)0.05
    Hist Vol90.7%(High)

    Volume Flow

    VWAP$0.70
    OBV-148.3M
    AD Line-177.7M
    CMF (20d)-0.285

    Volume Metrics

    Avg Vol (20d)2.0M
    Vol Ratio1.0x
    VWMA (20d)$0.77

    Pivot Points

    R3$0.90
    R2$0.86
    R1$0.82
    Pivot Point$0.78
    S1$0.74
    S2$0.71
    S3$0.66

    Advanced Oscillators

    TSI-33.57
    Ultimate Osc42.8
    KST-211.02

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about CMPX

    News

    CMPX Valuation

    GNG's valuation label for CMPX is Undervalued.

    P/B
    0.9x
    All CMPX metrics

    CMPX Profitability: Margins, ROIC and FCF

    Compass Therapeutics (CMPX) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -49.0%
    CMPX financial statements

    Compass Therapeutics Competitors

    The companies most similar to Compass Therapeutics (CMPX) include Invivyd, Protara Therapeutics and Pyxis Oncology.

    Sector: Healthcare

    Companies most similar to Compass Therapeutics

    CMPX Analyst Ratings

    Compass Therapeutics (CMPX) has a Buy consensus from 15 analysts: 12 Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    15
    Strong Buy
    2
    Buy
    10
    Hold
    3
    Sell
    0
    Strong Sell
    0
    CMPX stock forecast

    CMPX Bull Case vs Bear Case

    Bull case

    • 80.0% of CMPX's analyst ratings are Buy or Strong Buy.

    Bear case

    • CMPX beat EPS estimates in 25.0% of its last 8 reported quarters.

    CMPX Earnings: Beat Rate and Next Report

    Compass Therapeutics (CMPX) beat the EPS estimate in 2 of the last 8 quarters (25.0%). Its next report is expected on Mar 3, 2027.

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -5.3%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.15
    CMPX earnings history

    CMPX Earnings Date

    CMPX reports Mar 3, 2027. The date is estimated.

    See insider activity

    Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About CMPX

    When does CMPX report earnings?

    Compass Therapeutics Inc. (CMPX) is expected to report earnings on Mar 3, 2027.

    Does CMPX pay dividends?

    Compass Therapeutics Inc. (CMPX) does not currently pay a regular dividend.

    What is CMPX's market cap?

    Compass Therapeutics Inc. (CMPX) has a market capitalization of $139.35M with a current stock price of $0.66.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.